MREO
USDMereo BioPharma Group plc American Depositary Shares
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.830
Kõrge
$1.880
Madal
$1.780
Maht
1.12M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
283.2M
Tööstusharu
Biotehnoloogia
Riik
United Kingdom
Kauplemisstatistika
Keskmine maht
1.32M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO). Such investors...
JP Morgan Maintains Overweight on Mereo BioPharma Group, Raises Price Target to $8
JP Morgan analyst Priyanka Grover maintains Mereo BioPharma Group with a Overweight and raises the price target from $7 to $8.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO). Such investors...
āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2
- Company's second clinical-stage asset licensed from Mereo Biopharma based on novel insights generated in a mouse model of osteopetrosis - - āshibio has exclusive license to develop and commercialize vantictumab
Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta expected around year-end 2025 Cash of $56.1 million as of June 30, 2025, expected to support operations into 2027 LONDON, Aug. 12,
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO). Such investors...
Seotud aktsiad
RNA
Avidity Biosciences Inc.
NWG
NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)
JSPRW
Japer Therapeutics Inc. Warrants
ACRS
Aclaris Therapeutics Inc.
TERN
Terns Pharmaceuticals Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.